These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4579712)

  • 1. [Rifampicin and ethambutol in the treatment of chronic, destructive forms of pulmonary tuberculosis].
    Chmelev NA; Korotajev GA; Kaminskaja AA
    G Ital Chemioter; 1972; 19(2):1-6. PubMed ID: 4579712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5146090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
    Anastasatu K; Sibila S; Kaufman S; Bercha O; Vais F
    Probl Tuberk; 1972; 50(5):28-30. PubMed ID: 5029675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].
    Alimov ShA; Stoianovskiĭ EA
    Probl Tuberk; 1976; 3():27-31. PubMed ID: 967851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5162993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1976 Nov; (11):44-9. PubMed ID: 1019127
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 13. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
    Tani P
    Scand J Respir Dis Suppl; 1969; 69():15-6. PubMed ID: 4313500
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of treatment of chronic tuberculosis with rifampicin and ethambutol at the sanatoria run by the Railroad Health Services].
    Ropek M; Bielecki T; Mysakowska H; Sosnowski K; Raczyński R; Pizlo S; Majchrzak A
    Gruzlica; 1974 May; 42(5):393-5. PubMed ID: 4464225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
    Rudoĭ NM; Zankisova IG; Eĭsaev BA
    Antibiotiki; 1975 Oct; 20(10):945-8. PubMed ID: 813565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Chertkova MA; Pavlenko AV
    Probl Tuberk; 1975; (10):44-8. PubMed ID: 1208440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tolerance of rifampicin and ethambutol and their effects on liver function during treatment of patients with destructive lung tuberculosis].
    Kalankhodzhaev AA; Stoianovskiĭ EA; Ginzburg VS
    Probl Tuberk; 1978 Mar; (3):19-23. PubMed ID: 652761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
    Kraan JK; Mulder RJ; van Dijk B
    Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.